Norway Genomics Market Size & Outlook, 2023-2030
Norway genomics market, 2018-2030 (US$M)
Related Markets
Norway genomics market highlights
- The Norway genomics market generated a revenue of USD 229.7 million in 2023 and is expected to reach USD 509.2 million by 2030.
- The Norway market is expected to grow at a CAGR of 12% from 2024 to 2030.
- In terms of segment, functional genomics was the largest revenue generating application in 2023.
- Pathway Analysis is the most lucrative application segment registering the fastest growth during the forecast period.
Genomics market data book summary
| Market revenue in 2023 | USD 229.7 million |
| Market revenue in 2030 | USD 509.2 million |
| Growth rate | 12% (CAGR from 2023 to 2030) |
| Largest segment | Functional genomics |
| Fastest growing segment | Pathway Analysis |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Functional Genomics, Epigenomics, Pathway Analysis, Biomarker Discovery |
| Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Eppendorf, Eurofins Scientific SE, Roche Holding AG ADR, GE Aerospace, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies PLC, Pacific Biosciences of California Inc, Qiagen NV, Quest Diagnostics Inc, Thermo Fisher Scientific Inc, 23andMe Holding Co Class A |
Other key industry trends
- In terms of revenue, Norway accounted for 0.7% of the global genomics market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Spain genomics market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 3,005.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genomics Market Scope
Genomics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Norway genomics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genomics market will help companies and investors design strategic landscapes.
Functional genomics was the largest segment with a revenue share of 31.26% in 2023. Horizon Databook has segmented the Norway genomics market based on functional genomics, epigenomics, pathway analysis, biomarker discovery covering the revenue growth of each sub-segment from 2018 to 2030.
The Norwegian Sequencing Centre (NSC) was founded in 2009 to make high-throughput sequencing capabilities available to the Norwegian research community. A number of organizations, including Health South-East, the University of Oslo, and the Norwegian Research Council, have provided funding.
Furthermore, in December 2021, Illumina, Inc. announced that it is supporting Norway's Precision Medicine Study. The study aims to evaluate the effectiveness of Comprehensive Genomic Profiling (CGP) based on blood samples for cancer therapy selection.
Furthermore, increasing funding related to gene therapy in the country is expected to create growth opportunities for market growth. For instance, in December 2022, Haapaniemi group approved around USD 2 million (20m NOK) to develop a clinical trial with genome-edited T cells.
Reasons to subscribe to Norway genomics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Norway genomics market databook
-
Our clientele includes a mix of genomics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway genomics market , including forecasts for subscribers. This country databook contains high-level insights into Norway genomics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Norway genomics market size, by application, 2018-2030 (US$M)
Norway Genomics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
